Cognizant to Present at the Bank of America Merrill Lynch 2015 Global Technology Conference
Get Alerts CTSH Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 1.2%
EPS Growth %: 0.0%
Join SI Premium – FREE
TEANECK, N.J., May 27, 2015 /PRNewswire/ -- Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced that Karen McLoughlin, Chief Financial Officer, and Rajeev Mehta, Chief Executive Officer, IT Services, will present at the following investor conference:
Bank of America Merrill Lynch 2015 Global Technology Conference
- Date: Wednesday, June 3, 2015
- Time: 12:15 PM ET
Live audio webcast of this presentation will be available at Cognizant's website:
http://investors.cognizant.com
A replay of the webcast will remain available on the company's website for 90 days.
About Cognizant
Cognizant (NASDAQ: CTSH) is a leading provider of information technology, consulting, and business process outsourcing services, dedicated to helping the world's leading companies build stronger businesses. Headquartered in Teaneck, New Jersey (U.S.), Cognizant combines a passion for client satisfaction, technology innovation, deep industry and business process expertise, and a global, collaborative workforce that embodies the future of work. With over 100 development and delivery centers worldwide and approximately 217,700 employees as of March 31, 2015, Cognizant is a member of the NASDAQ-100, the S&P 500, the Forbes Global 2000, and the Fortune 500 and is ranked among the top performing and fastest growing companies in the world. Visit us online at www.cognizant.com or follow us on Twitter: Cognizant.
Logo - http://photos.prnewswire.com/prnh/20110329/NY67603LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cognizant-to-present-at-the-bank-of-america-merrill-lynch-2015-global-technology-conference-300089567.html
SOURCE Cognizant
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IT services stocks fall following Infosys' numbers
- U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
- WorldTrips Wins Gold 2024 Stevie® Award
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!